Dry Mouth After 50: Why Your Medication List May Matter More Than You Think

Dry mouth becomes more common as we get older. That does not mean it should automatically be dismissed as a normal part of aging.

Age can affect the salivary glands, and some studies have found lower salivary flow in older adults. But medications matter too, particularly when several are taken together. For someone who develops a noticeably drier mouth in their fifties, sixties or seventies, the medication list is therefore one of the first things worth reviewing.

That matters because dry mouth is not simply uncomfortable. When salivary protection falls sufficiently, the risk to the teeth changes as well.

First, dry mouth and low saliva are not quite the same thing

Dentists use two related terms.

Xerostomia means the subjective sensation that your mouth feels dry.

Hyposalivation means that salivary flow is objectively reduced when it is measured.

The two overlap, but they are not interchangeable. A study of dentate older adults found that some people reporting xerostomia did not have objectively low salivary flow, while reduced flow could also occur without a strong subjective complaint. [4]

That distinction matters clinically.

If your mouth feels dry, there may be a salivary problem, but the symptom alone does not tell your dentist how much saliva you are actually producing. Conversely, the absence of severe dryness does not guarantee normal salivary function.

Aging does affect saliva, but the story is more complicated than "you are getting older"

Researchers have been studying this question for decades, and the results are not completely uniform.

In a study comparing younger and older adults, resting whole salivary flow was lower in older participants, although their ability to increase saliva in response to stimulation was relatively well preserved. [1] Other population studies have also found age-associated changes in salivary gland function. [2]

A large population study of adults aged 20 to 69 found that age and medication use both contributed to the likelihood of low salivary flow. [3]

So the accurate conclusion is not that aging has no effect.

It is this:

Aging can affect salivary function, but medications and medical conditions are important additional contributors and should not be overlooked.

That is particularly relevant after 50, when the number of regularly used medications often begins to increase.

Medications can make a measurable difference

The association between medication use and salivary function is not based simply on patients reporting that their mouths feel dry.

Researchers can measure it.

The most comprehensive assessment of this question is a systematic review conducted for the World Workshop on Oral Medicine VI, which evaluated the evidence linking specific medications to salivary gland dysfunction and graded the strength of that evidence drug by drug. [5] It remains the reference point against which individual studies should be read.

Among those individual studies, a multicenter analysis of patients with xerostomia examined medication exposure together with unstimulated and chewing-stimulated salivary flow. Lower flow rates were associated with several medication groups. After matching patients for other factors, antidepressant use remained associated with lower unstimulated salivary flow, while corticosteroids and disease-modifying antirheumatic drugs were associated with lower stimulated flow. The effects were also greater in patients taking multiple drugs from some medication classes. [6]

That does not mean everyone taking an antidepressant, antihypertensive or another implicated drug will develop dry mouth. These are associations, and individual response varies.

One pharmacological mechanism, however, is particularly well established.

Anticholinergic burden matters

Salivary secretion is strongly influenced by parasympathetic cholinergic signaling. Drugs with anticholinergic activity can interfere with that signaling.

The important issue is not always one obviously anticholinergic medication. Several medications with anticholinergic activity can contribute to a cumulative burden.

In a study of community-dwelling older adults, people with a high anticholinergic burden were substantially more likely to report xerostomia than those with no measured anticholinergic burden, and were also more likely to have very low unstimulated salivary flow. [7] A companion study by the same group in middle-aged people found a comparable pattern, which matters for anyone noticing these changes well before old age. [8]

That is one reason a complete medication review matters.

Prescription medications are not the only products worth mentioning. Over-the-counter medicines should also be included when you discuss dry mouth with your dentist, physician or pharmacist.

What about GLP-1 medications?

This deserves particular care because dry mouth is sometimes discussed online as if it were an established effect of every GLP-1 medication.

The evidence does not support that conclusion.

The current FDA prescribing information for Zepbound, or tirzepatide, lists dry mouth or dry throat among adverse reactions reported in pooled weight-management trials at a higher rate than placebo. [16]

For Saxenda, or liraglutide, dry mouth likewise appears in the prescribing information among common adverse reactions occurring at a higher incidence in treated adults than in those receiving placebo. [17]

By contrast, dry mouth is not listed among the identified common adverse reactions in the current prescribing information for Wegovy, or semaglutide. [18]

So it is inaccurate to say that GLP-1 receptor agonists universally cause dry mouth.

A better conclusion is that dry mouth has been documented with some GLP-1-based medications, but the evidence varies by drug and it should not currently be treated as a uniform class effect.

If significant dryness begins after starting or increasing any medication, the timing is worth documenting and discussing with the prescriber. Timing alone, however, does not prove that the drug caused it.

Why reduced saliva matters to your teeth

Saliva does much more than make the mouth feel wet.

It contributes to clearance of food and acids from tooth surfaces and helps maintain the chemical environment around enamel and exposed root surfaces.

For older adults, exposed root surfaces are particularly important. Gum recession becomes more common over time, leaving dentin and cementum exposed rather than enamel.

Root caries is associated with several factors, and xerostomia is one of the risk indicators identified in studies of independently living older adults. [9]

This does not mean that everyone with dry mouth will develop rampant decay.

It means that persistent xerostomia or objectively low salivary flow should change how caries risk is assessed.

A person who has had very little dental disease throughout adulthood can still become a higher-risk patient if the oral environment changes.

The first useful step is a medication review

If your mouth has become persistently dry, make a list of everything you take regularly.

That includes prescription medicines and over-the-counter products.

Then discuss the list with the clinician who manages your medications or with a pharmacist.

The purpose is not to stop medicines simply because dry mouth is listed as a possible adverse effect.

It is to determine whether any of the following are possible:

• a medication is no longer necessary
• the dose can appropriately be changed
• an alternative medication could achieve the same clinical purpose with fewer oral adverse effects
• several medications are contributing to cumulative anticholinergic burden

Those decisions belong with the prescriber.

Do not stop, reduce or change the timing of a prescription on your own. The dental consequences of dry mouth need to be managed without compromising treatment of the underlying medical condition.

Protect the teeth while you investigate the cause

You do not need to know the exact cause of the dryness before addressing an increased risk of decay.

Ask your dentist to assess your caries risk

Persistent xerostomia is worth mentioning specifically rather than simply waiting for your next routine examination.

Depending on your history and clinical findings, your dentist may assess salivary function, look for new or early root lesions, review exposed root surfaces and alter your preventive plan.

The appropriate recall interval should be individualized rather than automatically changing every patient with dry mouth to a three-month schedule.

Ask whether high-fluoride toothpaste is appropriate

For adults at high risk of root caries, prescription-strength fluoride toothpaste has unusually good direct clinical evidence, and the most relevant trial was conducted in exactly the population likely to be reading this.

A two-year double-blind randomized controlled trial in 345 independently living older adults, each with at least one root caries lesion, compared brushing twice daily with 5,000 ppm fluoride toothpaste against conventional 1,450 ppm toothpaste. [10] A later analysis of the same trial data reported that among lesions treated with the high-fluoride toothpaste, 64 percent were active at the start, became inactive at one year, and remained inactive at two years. [11]

Supporting evidence comes from other populations. A randomized trial in elderly disabled nursing home residents, a considerably more compromised group than community-dwelling adults, found 5,000 ppm fluoride toothpaste more effective than 1,450 ppm at controlling root caries progression. [12] A separate multicenter randomized trial in adults likewise found greater benefit from high-fluoride toothpaste. [13]

That does not mean everyone who occasionally feels dry needs prescription fluoride.

It means that for someone whose dry mouth is accompanied by high caries risk, exposed roots or active disease, it is worth discussing with a dentist.

Symptom relief is separate from caries prevention

Artificial-saliva products and oral moisturizers may relieve the sensation of dryness, although response varies substantially between patients and products.

In a crossover study of patients with severe xerostomia after head-and-neck radiotherapy, several saliva-substitute formulations improved symptoms, but no single formulation was clearly superior across patients. [14]

This is an important distinction.

Making the mouth feel wetter and reducing the risk of dental decay are not necessarily the same intervention.

A moisturizing product may improve comfort. Fluoride and control of dietary sugar and acid exposure address dental risk through different mechanisms.

Prescription drugs that stimulate saliva exist, but they are not for everyone

Two medications commonly discussed in severe dry mouth are pilocarpine and cevimeline.

Their FDA-approved uses are specific.

Pilocarpine is approved for symptoms of dry mouth caused by salivary-gland hypofunction following radiotherapy for head and neck cancer and for symptoms of dry mouth in patients with Sjögren syndrome. [19]

Cevimeline is approved for treatment of dry-mouth symptoms in patients with Sjögren syndrome. [20]

Neither should be thought of as an automatic treatment for ordinary medication-associated dry mouth. Both have systemic effects and contraindications that need to be considered by the prescribing clinician.

When dry mouth deserves a medical workup

Medication is only one possible explanation.

Persistent dry mouth may also occur in the setting of systemic disease, salivary-gland disease or previous cancer treatment. Sjögren syndrome is particularly relevant when significant oral dryness occurs together with persistent dry-eye symptoms.

Head-and-neck radiotherapy can also produce substantial salivary dysfunction.

A sudden or unexplained change in salivary function therefore deserves assessment rather than being automatically attributed to age or treated indefinitely with over-the-counter products.

The bottom line

Dry mouth after 50 is common, but "I am getting older" is not a sufficient explanation.

Aging itself can change salivary function. At the same time, medication exposure, polypharmacy and particularly cumulative anticholinergic burden can have measurable effects on saliva.

That distinction matters because age cannot be modified, while a medication regimen can at least be reviewed.

If your mouth has become persistently dry, particularly after a change in medication, two conversations are worthwhile:

Tell your prescriber or pharmacist. Tell your dentist.

The first can help determine why the dryness is happening.

The second can determine whether it has changed your risk of dental disease and whether your preventive strategy needs to change.

Dry mouth should not be treated as an inevitable inconvenience of getting older, and it should not be ignored until the first cavity appears.

Primary sources

1. Percival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. Journal of Dental Research. 1994;73(8):1416-1420.

2. Yeh CK, Johnson DA, Dodds MW. Impact of aging on human salivary gland function: a community-based study. Aging (Milano). 1998;10(5):421-428. doi:10.1007/BF03339889.

3. Flink H, Bergdahl M, Tegelberg Å, Rosenblad A, Lagerlöf F. Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dentistry and Oral Epidemiology. 2008;36(6):523-531.

4. Wiener RC, Wu B, Crout R, et al. Hyposalivation and xerostomia in dentate older adults. Journal of the American Dental Association. 2010;141(3):279-284.

5. Villa A, Wolff A, Narayana N, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Diseases. 2016;22(5):365-382.

6. Fortuna G, Whitmire S, Sullivan K, et al. Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium. Clinical Oral Investigations. 2023;27(1):235-248. doi:10.1007/s00784-022-04717-1.

7. Tiisanoja A, Syrjälä AM, Komulainen K, Lampela P, Hartikainen S, Taipale H, Knuuttila M, Ylöstalo P. Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults. Gerodontology. 2018;35(1):3-10. doi:10.1111/ger.12304.

8. Tiisanoja A, Syrjälä AMH, Kullaa A, Ylöstalo P. Anticholinergic burden and dry mouth in middle-aged people. JDR Clinical and Translational Research. 2020. doi:10.1177/2380084419844511.

9. Hayes M, Da Mata C, Cole M, McKenna G, Burke F, Allen PF. Risk indicators associated with root caries in independently living older adults. Journal of Dentistry. 2016.

10. High fluoride dentifrice for preventing and arresting root caries in community-dwelling older adults: a randomized controlled clinical trial. Journal of Dentistry. 2019.

11. Dynamics of root caries in older adults using high-fluoride toothpaste. Journal of Dentistry. 2025.

12. Ekstrand KR, Poulsen JE, Hede B, Twetman S, Qvist V, Ellwood RP. A randomized clinical trial of the anti-caries efficacy of 5,000 compared to 1,450 ppm fluoridated toothpaste on root caries lesions in elderly disabled nursing home residents. Caries Research. 2013;47(5):391-398. doi:10.1159/000348581.

13. Srinivasan M, Schimmel M, Riesen M, et al. High-fluoride toothpaste: a multicenter randomized controlled trial in adults. Community Dentistry and Oral Epidemiology. 2014.

14. Momm F, Volegova-Neher NJ, Schulte-Mönting J, Guttenberger R. Different saliva substitutes for treatment of xerostomia following radiotherapy. Strahlentherapie und Onkologie. 2005;181:231-236.

15. Reserved.

16. U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information.

17. U.S. Food and Drug Administration. Saxenda (liraglutide) Prescribing Information.

18. U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information.

19. U.S. Food and Drug Administration. Salagen (pilocarpine hydrochloride) Prescribing Information.

20. U.S. prescribing information for cevimeline hydrochloride.